Molecularly Imprinted Polymers for commercial applications.
Molecularly imprinted polymers (MIPs) are a synthetic alternative to antibodies with unique robustness characteristics.
Synthetic affinity reagents for diagnostics and healthcare.
MIP Discovery is the leading developer of non-biological affinity reagents, nanoMIPs, for diagnostics and healthcare appications. nanoMIP technology allows for the rapid development of polymer based affinity reagents targeted to small molecules, proteins and viruses, amongst other targets.
Rationally designed and chemically manufactured, nanoMIPs are completely animal free, offer simplified logistics, and can be developed much more rapidly than biological alternatives, such as antibodies. Alongside an advantageous supply chain, they also deliver on performance, continually demonstrating high specificity, sensitivity, and stability under extreme conditions.
Learn more about nanoMIPTM technology
Watch a 5 minute introduction to nanoMIPs
In this short video, Senior Scientist Rhiannon Johnson explains exactly what molecularly imprinted polymers (MIPs) are and the different ways in which they can be made.
Read our publications on advancing
Visit our library of publications on nanoMIP technology, covering a wide variety of applications.